In a clinical practice guideline issued by the American Society for Radiation Oncology and published online Nov. 25 in ...

1 These data support the conclusion that patients who respond to preoperative chemoradiation therapy, who in this study were represented to a greater degree in the LAR group than in the APR group ...

Given the unfavorable long-term prognosis of patients who receive chemoradiation alone—only about 36% survive at least five years, according to Li—there is a desperate need for improved ...

Summary and Introduction Clinical Application—Disease Entities Theoretical Framework for Therapy−The 'Steel Paradigm' Conclusion References Theoretical Framework for Therapy−The 'Steel ...

Given the unfavorable long-term prognosis of patients who receive chemoradiation alone—only about 36% survive at least five years, according to Li—there is a desperate need for improved ...

Third, chemotherapy given as part of concurrent chemoradiation may act systemically and potentially eradicate distant micrometastases.

Chemoradiation has been the standard treatment for cervical cancer since 1999, but despite improvements in care, cancer ...

Neoadjuvant chemoradiation can reduce the tumor volume and pathologic tumor stage of locally advanced rectal cancer, increasing the likelihood of curative surgical resectability and improving long ...

The American Society for Radiation Oncology (ASTRO) issued today an updated clinical guideline for physicians who use ...

The American Society for Radiation Oncology (ASTRO) issued today an updated clinical guideline for physicians who use radiation therapy to treat patients with locally advanced rectal cancer. This ...

Tagrisso has been recommended for approval in the European Union for the treatment of adult patients with locally advanced, unresectable non-small cell lung cancer, or NSCLC, whose tumors have ...